Restasis and Multaq drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Restasis (cyclosporine) and Multaq (dronedarone hydrochloride). Common drug interactions include pruritus among females and eye irritation among males.
The phase IV clinical study analyzes what interactions people have when they take Restasis and Multaq. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
What is Multaq?
Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.
37 people who take Restasis and Multaq together, and have interactions are studied.

What are the common drug interactions of Restasis and Multaq, by gender? *:
female:
- Pruritus (severe itching of the skin)
- Rash
- Erythema (redness of the skin)
- Glaucoma (increased fluid pressure in the eye with vision loss)
- Urine calcium increased
- Skin burning sensation
- Anxiety
- Dyspnoea (difficult or laboured respiration)
- Feeling hot
- Blood pressure increased
male:
- Eye irritation
- Dysphagia (a condition in which swallowing is difficult or painful)
- Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
- Tinnitus (a ringing in the ears)
- Tooth disorder (tooth disease)
- Vitamin d decreased
- Vitreous floaters (spots before the eyes)
- Blood sodium decreased
- Constipation
- Cystitis (inflammation of the wall of the bladder)
What are the common drug interactions of Restasis and Multaq, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Pneumonia
60+:
- Anxiety
- Dysphagia (a condition in which swallowing is difficult or painful)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hallucination (an experience involving the perception of something not present)
- Heart rate increased
- Muscular weakness (muscle weakness)
- Weight decreased
- Abdominal discomfort
- Alanine aminotransferase increased
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Pain: 5 people, 13.51%
- High Blood Cholesterol: 4 people, 10.81%
- Headache (pain in head): 4 people, 10.81%
- Cardiac Disorder: 4 people, 10.81%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.11%
- Menopause (end of monthly cycles in women): 3 people, 8.11%
- High Blood Pressure: 3 people, 8.11%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%
- Multiple Myeloma (cancer of the plasma cells): 2 people, 5.41%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.41%
* Approximation only. Some reports may have incomplete information.
Do you take Restasis and Multaq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Restasis and Multaq:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Multaq:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Multaq and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and dronedarone hydrochloride (the active ingredients of Restasis and Multaq, respectively), and Restasis and Multaq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Levemir cause Hypokalemia? - 4 seconds ago
- Zomig vs. Butalbital, Acetaminophen And Caffeine, side effect and effectiveness comparison - 11 seconds ago
- Blood Sodium Decreased and drugs of ingredients of codeine sulfate - 14 seconds ago
- Pneumonia and Blood Pressure Systolic Decreased - 31 seconds ago
- Polyfollicular Ovarian Disease in Vitamin D, how severe and when it was recovered? - 31 seconds ago
- Polycystic Ovary Disease in Vitamin D, how severe and when it was recovered? - 32 seconds ago
- Hypericum Perforatum vs. Lamictal, side effect and effectiveness comparison - 34 seconds ago
- Avapro vs. Klor-Con M10, side effect and effectiveness comparison - 38 seconds ago
- Could Duragesic cause Metabolic Encephalopathy? - 38 seconds ago
- Trexall vs. Ergocalciferol, side effect and effectiveness comparison - 42 seconds ago